Cornell Institute for Disease & Disaster Preparedness

The Cornell Institute for Disease and Disaster Preparedness (CIDDP), co-directed by Dr. Nathaniel Hupert (Weill Cornell Medicine) and Prof. Jack Muckstadt (Cornell Engineering), grew out of many years of collaborative work involving a range of academic specialties related to preparation for and response to natural and man-made disasters and disease epidemics.

CIDDP efforts advance research and education in the field of public health response logistics, the systematic study of physical and human infrastructures, materials and supplies, transport resources, information and communication systems, business processes, decision support systems and command and control systems required to respond quickly and appropriately to health crises.

Interlinked Goals

  • Primary research through theoretical modeling, model validation activities and development of decision support tools for improved health system response to pressing threats including COVID-19, pandemic influenza, bioterrorism and other emerging infections such as Ebola Virus Disease (EVD)
  • Education of the nation's next generation of engineers and public health practitioners and researchers, with combined expertise in both the quantitative techniques of operations research (simulation, mathematical modeling and statistical analysis) and the applied field of public health system research
  • Outreach to end-users, including hospitals, health systems, federal, state, regional and local public health officials, insurance and risk management entities, data integrators and information system developers capable of translating pilot projects into widely available decision support tools

Pandemic Response Planning Tools

COVID-19 Research

Other CIDDP Research

Non-COVID Response Logistics Modeling Tools and Reports


Key Personnel

Vaccine Distribution Model

Major Weill Cornell Medicine Public Health Response Logistics Models and Reports

DateModel NameClientDevelopment Lead
2002Weill Cornell Medicine Bioterrorism and Epidemic Outbreak ResponseU.S. Health & Human Services (HHS), Agency for Healthcare Research and Quality (AHRQ)N. Hupert, D. Wattson
2004Community-Based Mass Prophylaxis: A Planning Guide for Public Health PreparednessU.S. HHS AHRQN. Hupert, J. Cuomo and S. Morse
2004-09Regional Hospital Caseload CalculatorU.S. HHS AHRQN. Hupert, J. Cuomo and D. Wattson
2005Hospital Surge Capacity Optimization and Utilization ToolU.S. HHS AHRQN. Hupert and D. Wattson
2005-07Catastrophic Patient AllocationU.S. HHS AHRQJ. Muckstadt, S. Chinchalkar, N. Hupert and W. Xiong
2006Triage and Surge Capacity Tool (TriSCT)U.S. HHS AHRQ and Columbia University National Center for Disaster PreparednessN. Hupert, E. Hollingsworth and W. Xiong
2006-07Stochastic Simulation of Health System Response to Large-Scale EpidemicsJ. Muckstadt, D. Murray, P. Jackson, W. Xiong, E. Hollingsworth and N. Hupert
2007LabModClinton Foundation HIV/AIDS InitiativeW. Xiong, E. Hollingsworth and N. Hupert
2007Hospital Self-ProphylaxisNewYork-Presbyterian HospitalW. Xiong, E. Hollingsworth, N. Hupert, J. Muckstadt, J. Vorenkamp and E. Lazar
2007Stochastic HIV/AIDS Treatment Scale-Up in Sub-Saharan AfricaClinton Foundation HIV/AIDS InitiativeJ. Muckstadt, M. Al-Gwaiz, W. Xiong, K. King, E. Hollingsworth and N. Hupert
2008-09Hospital Preparedness Exercises Guidebook; Pocket Guide and Atlas of Resources and ToolsU.S. HHS AHRQM. Cheung M, A-T. Vu, D D. Varlese, W. Xiong and N. Hupert
2010-14Pharmaceutical-Based Antiviral Dispensing for Pandemic InfluenzaU.S. Centers for Disease Control (CDC)N. Hupert, J. Muckstadt, C. Barnett, R. Chen and K. King

Current Research Highlights

Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880–2018: A Systematic Review

October 18, 2022

Anthrax is a bacterial toxin-mediated zoonotic disease caused by Bacillus anthracis. It has been recognized for millennia and is considered a potential biowarfare agent. In a new Clinical Infectious Diseases study, Dr. Nathaniel Hupert and colleagues conduct a systematic review of English language anthrax case reports from the past 135+...

Read More
Image of close up anthrax bacteria

Flu Shots, Measles Vaccines Could Also Help "Flatten the Curve" for COVID-19

January 10, 2022

While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic. The study, published Jan. 10 in the Proceedings of the National Academy of Sciences, crystallizes decades of evidence...

Read More
Healthcare provider administering a vaccine dose.

Extreme immunotherapy: emergency immunology to defeat pandemics

September 17, 2021

Scientists have learned much about physical interventions, non-pharmaceutical interventions, and vaccination success throughout the course of the COVID-19 pandemic. However, therapeutic interventions have not been very effective, and successful antiviral drugs have not been introduced at scale. In a new perspective piece in BMC Molecular Medicine, ...

Read More
Virus illustration

Population Health Sciences 402 E. 67th St. New York, NY 10065 Phone: (646) 962-8001

Faculty & Staff

Nathaniel Hupert, M.D., MPH
Nathaniel Hupert , MD, MPH
  • Associate Professor of Population Health Sciences
  • Associate Professor of Medicine
(646) 962-8045
View Research Profile
Photo of Jack Muckstadt
John Anthony Muckstadt , Ph.D.
  • Acheson-Laibe Emeritus Professor of Engineering, Cornell University School of Operations Research and Information Engineering
  • Stephen H.Weiss Presidential Fellow

Cornell Institute for Disease and Disaster Preparedness
402 E. 67th St, New York, NY 10065